Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis - Zhang, Xiaoping; Goel, Varun; Robbie, Gabriel J. (Journal of clinical pharmacology, 2020)
Keywords: amyloidosis; lipid nanoparticle; patisiran; pharmacokinetics (PK); RNAi therapeutic; small interfering ribonucleic acid (siRNA); lipid nanoparticle; amyloidosis; patisiran; pharmacokinetics (PK); RNAi therapeutic; small interfering ribonucleic acid (siRNA)